Shiragami, M., Mizukami, A., Kaise, T., Curran, D., Van Oorschot, D., Bracke, B., & Watanabe, D. (2019). Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older. Dermatol Ther (Heidelb).
Stile di citazione ChicagoShiragami, Makoto, Akiko Mizukami, Toshihiko Kaise, Desmond Curran, Desiree Van Oorschot, Benjamin Bracke, e Daisuke Watanabe. "Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older." Dermatol Ther (Heidelb) 2019.
Citazione MLAShiragami, Makoto, et al. "Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older." Dermatol Ther (Heidelb) 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.